99 related articles for article (PubMed ID: 9353379)
1. Exacerbation of methamphetamine-induced neurochemical deficits by melatonin.
Gibb JW; Bush L; Hanson GR
J Pharmacol Exp Ther; 1997 Nov; 283(2):630-5. PubMed ID: 9353379
[TBL] [Abstract][Full Text] [Related]
2. Melatonin attenuates methamphetamine-induced reduction of tyrosine hydroxylase, synaptophysin and growth-associated protein-43 levels in the neonatal rat brain.
Kaewsuk S; Sae-ung K; Phansuwan-Pujito P; Govitrapong P
Neurochem Int; 2009 Nov; 55(6):397-405. PubMed ID: 19409439
[TBL] [Abstract][Full Text] [Related]
3. Role of the 5-HT2 receptor in the methamphetamine-induced neurochemical alterations.
Johnson M; Sonsalla PK; Letter AA; Hanson GR; Gibb JW
J Pharmacol Exp Ther; 1994 Jul; 270(1):97-103. PubMed ID: 7913500
[TBL] [Abstract][Full Text] [Related]
4. The effects of amphetamine-like designer drugs on monoaminergic systems in rat brain.
Gibb JW; Stone DM; Stahl DC; Hanson GR
NIDA Res Monogr; 1987; 76():316-21. PubMed ID: 2449619
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain.
Hotchkiss AJ; Gibb JW
J Pharmacol Exp Ther; 1980 Aug; 214(2):257-62. PubMed ID: 6104722
[TBL] [Abstract][Full Text] [Related]
6. Role of dopamine in the neurotoxic effects of methamphetamine.
Schmidt CJ; Ritter JK; Sonsalla PK; Hanson GR; Gibb JW
J Pharmacol Exp Ther; 1985 Jun; 233(3):539-44. PubMed ID: 2409267
[TBL] [Abstract][Full Text] [Related]
7. Interaction between hyperthermia and oxygen radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine administration.
Fleckenstein AE; Wilkins DG; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1997 Oct; 283(1):281-5. PubMed ID: 9336334
[TBL] [Abstract][Full Text] [Related]
8. Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3,4-methylenedioxymethamphetamine.
Johnson M; Mitros K; Stone DM; Zobrist R; Hanson GR; Gibb JW
J Pharmacol Exp Ther; 1992 May; 261(2):586-91. PubMed ID: 1374469
[TBL] [Abstract][Full Text] [Related]
9. Methamphetamine exposure during the preweanling period causes prolonged changes in dorsal striatal protein kinase A activity, dopamine D2-like binding sites, and dopamine content.
Crawford CA; Williams MT; Newman ER; McDougall SA; Vorhees CV
Synapse; 2003 Jun; 48(3):131-7. PubMed ID: 12645038
[TBL] [Abstract][Full Text] [Related]
10. Neurochemical basis of neurotoxicity.
Gibb JW; Johnson M; Hanson GR
Neurotoxicology; 1990; 11(2):317-21. PubMed ID: 1978271
[TBL] [Abstract][Full Text] [Related]
11. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity.
Itzhak Y; Gandia C; Huang PL; Ali SF
J Pharmacol Exp Ther; 1998 Mar; 284(3):1040-7. PubMed ID: 9495865
[TBL] [Abstract][Full Text] [Related]
12. Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum.
Eyerman DJ; Yamamoto BK
J Pharmacol Exp Ther; 2005 Jan; 312(1):160-9. PubMed ID: 15331654
[TBL] [Abstract][Full Text] [Related]
13. Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment.
Lu P; Mamiya T; Lu L; Mouri A; Niwa M; Kim HC; Zou LB; Nagai T; Yamada K; Ikejima T; Nabeshima T
Behav Brain Res; 2010 Mar; 207(2):387-93. PubMed ID: 19857526
[TBL] [Abstract][Full Text] [Related]
14. The effects of high-dose methamphetamine in the aging rat: differential reinforcement of low-rate 72-s schedule behavior and neurochemistry.
Sabol KE; Richards JB; Yung K
J Pharmacol Exp Ther; 2000 Sep; 294(3):850-63. PubMed ID: 10945833
[TBL] [Abstract][Full Text] [Related]
15. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
Bjorklund NL; Sorg BA; Schenk JO
Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
[TBL] [Abstract][Full Text] [Related]
16. Effects of a single dose of methamphetamine and iprindole on the serotonergic and dopaminergic system of the rat brain.
Peat MA; Warren PF; Gibb JW
J Pharmacol Exp Ther; 1983 Apr; 225(1):126-31. PubMed ID: 6187915
[TBL] [Abstract][Full Text] [Related]
17. Chronic melatonin treatment and its precursor L-tryptophan improve the monoaminergic neurotransmission and related behavior in the aged rat brain.
Esteban S; Garau C; Aparicio S; Moranta D; Barceló P; Fiol MA; Rial R
J Pineal Res; 2010 Mar; 48(2):170-7. PubMed ID: 20082664
[TBL] [Abstract][Full Text] [Related]
18. Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine.
Chapman DE; Hanson GR; Kesner RP; Keefe KA
J Pharmacol Exp Ther; 2001 Feb; 296(2):520-7. PubMed ID: 11160639
[TBL] [Abstract][Full Text] [Related]
19. Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine.
Cass WA; Smith MP; Peters LE
Ann N Y Acad Sci; 2006 Aug; 1074():261-71. PubMed ID: 17105922
[TBL] [Abstract][Full Text] [Related]
20. Neurochemical basis for cocaine and methamphetamine interactions.
Hanson G; Matsuda L; Gibb J
NIDA Res Monogr; 1988; 81():94-100. PubMed ID: 2457162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
